Welcome to our dedicated page for Bio-Key Intl SEC filings (Ticker: BKYI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
BIO-key International, Inc. filings document the formal disclosures of an IAM and biometric authentication company, including operating results and financial condition in Form 8-K reports, press-release exhibits, and the company’s Form 12b-25 notice for a delayed annual report. The records also capture disclosures tied to software license renewals, hardware revenue activity, and cash-position commentary.
Proxy and current-report filings cover stockholder voting, certificate amendments, and material modifications to security-holder rights related to the 1-for-10 reverse stock split. The filing record also includes Nasdaq continued-listing notices tied to periodic-report timing, capital-structure disclosures, governance procedures, and meeting mechanics for common stockholders.
BIO-key International, Inc. (BKYI) filed its Definitive Proxy Statement (DEF 14A) for the 2025 Annual Meeting of Stockholders, scheduled for August 8 2025 at 10:00 a.m. (ET) at the company’s Holmdel, NJ headquarters. The record date is June 20 2025, when 6,848,775 common shares were outstanding, with each share entitled to one vote and no cumulative voting rights.
Shareholders will vote on six proposals: (1) election of five directors to serve until the 2026 meeting; (2) ratification of Bush & Associates CPA LLC as independent registered public accounting firm for FY 2025; (3) an advisory “say-on-pay” vote on executive compensation; (4) an amendment to the 2023 Stock Incentive Plan; (5) an amendment to the 2021 Employee Stock Purchase Plan; and (6) other routine business. Boxes for a preliminary proxy, confidential treatment, additional materials, and soliciting material are all unchecked, confirming that this filing is the definitive statement.
The proxy materials, together with the company’s Form 10-K for the year ended December 31 2024, were first mailed on or about June 27 2025. Registered shareholders may vote in person, by mail, telephone, or internet; beneficial owners must follow their broker’s instructions. Brokers lack discretionary authority to vote uninstructed shares on Proposals 1, 3, 4, or 5, potentially resulting in broker non-votes for those items.
The filing includes a detailed table of contents covering governance, principal stockholders, executive and director compensation, and full text of the amended stock plans (Appendices A & B). No filing fee was required. Aside from the requested plan amendments, the proxy does not disclose new financial metrics, acquisitions, or other extraordinary actions.